Latest News for: plasmacytoid

Edit

Menarini Group Announces Collaboration with VisualDx to Aid in Identifying People Who May Have Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

PR Newswire 20 Mar 2025
The BPDCN cell of origin is the plasmacytoid dendritic cell (pDC) precursor ... ELZONRIS is a prescription medicine used to treat blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults and pediatric patients 2 years and older.
Edit

Menarini Group Announces Collaboration with VisualDx to Aid in Identifying People Who May Have Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) (Stemline Therapeutics Inc)

Public Technologies 20 Mar 2025
The BPDCN cell of origin is the plasmacytoid dendritic cell (pDC) precursor ... ELZONRIS is a prescription medicine used to treat blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults and pediatric patients 2 years and older.
Edit

Menarini Group Announces Collaboration with VisualDx to Aid in Identifying People Who May Have Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) (A Menarini Industrie Farmaceutiche Riunite Srl)

Public Technologies 20 Mar 2025
The BPDCN cell of origin is the plasmacytoid dendritic cell (pDC) precursor ... ELZONRIS is a prescription medicine used to treat blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults and pediatric patients 2 years and older.
  • 1
×